In Vivo and Ex Vivo Prostate Cancer Imaging Using an Ultrasonic Tissue-Typing Technique for Imaging-Guided Dose Escalation of Prostate Cancer Radiotherapy
T Liu,RD Ennis,PB Schiff,SA Ko,M Mansukhani,MC Benson,EJ Feleppa,P Lee,JA Ketterling,FL Lizzi,GJ Kutcher
DOI: https://doi.org/10.1016/j.ijrobp.2004.07.045
2004-01-01
Abstract:Purpose/ObjectiveA series of studies were conducted to determine how well an ultrasonic tissue-typing technique can identify cancer-bearing regions inside the prostate. These studies were undertaken with the ultimate goal of localizing cancerous regions inside the prostate to guide tumor dose escalation for both IMRT and brachytherapy.Materials/MethodsUltrasonic tissue-typing imaging using spectrum analysis technique reveals the physical properties (e.g., size, shape and stiffness) of biological tissues noninvasively. Two studies were carried out, after IRB approval, to determine how well this ultrasound technique can differentiate cancerous tissues inside the prostate. Ten patients with localized prostate cancer were enrolled in the in vivo study. Each patient was scanned with a conventional transrectal ultrasound (BsK Medical System, Hawk, 7.5 MHz probe) before the brachytherapy procedure. 3-D ultrasound radio-frequency (rf) data were acquired in a sequence of parallel axial scans which were 1 mm apart. Prior prostate needle biopsies were used as the gold standard. For the ex vivo study, prostate specimens were immersed in saline and scanned with the same ultrasound system immediately after radical prostatectomy. Entire surgical specimens were then embedded for histologic examination. The ultrasound rf data were analyzed using a 2-D Fourier transform algorithm. The resulting spectral parameters of both cancerous regions and non-cancerous regions were computed to quantitatively assess the prostatic tissue.ResultsFor the in vivo study, 40 cancerous vs. 40 non-cancerous regions were analyzed. For the ex vivo study, 24 cancerous vs. 24 non-cancerous regions were analyzed. The size of each region analyzed is 4 mm × 4 mm. For both studies, significant differences between cancerous and non-cancerous regions were found in three 2-D ultrasonic parameters (p < 0.001): peak value of radially-integrated spectral power (RISP), slope and intercept of angularly-integrated spectral power (AISP).ConclusionsThe in vivo study demonstrated the feasibility of clinically employing this tissue-typing method for segmenting cancer-bearing regions inside the prostate. The ex vivo study further validated our ultrasound tissue-typing technique. These encouraging results in prostate cancer imaging are being used to plan additional studies in dose escalation of prostate cancer brachytherapy and IMRT Purpose/ObjectiveA series of studies were conducted to determine how well an ultrasonic tissue-typing technique can identify cancer-bearing regions inside the prostate. These studies were undertaken with the ultimate goal of localizing cancerous regions inside the prostate to guide tumor dose escalation for both IMRT and brachytherapy. A series of studies were conducted to determine how well an ultrasonic tissue-typing technique can identify cancer-bearing regions inside the prostate. These studies were undertaken with the ultimate goal of localizing cancerous regions inside the prostate to guide tumor dose escalation for both IMRT and brachytherapy. Materials/MethodsUltrasonic tissue-typing imaging using spectrum analysis technique reveals the physical properties (e.g., size, shape and stiffness) of biological tissues noninvasively. Two studies were carried out, after IRB approval, to determine how well this ultrasound technique can differentiate cancerous tissues inside the prostate. Ten patients with localized prostate cancer were enrolled in the in vivo study. Each patient was scanned with a conventional transrectal ultrasound (BsK Medical System, Hawk, 7.5 MHz probe) before the brachytherapy procedure. 3-D ultrasound radio-frequency (rf) data were acquired in a sequence of parallel axial scans which were 1 mm apart. Prior prostate needle biopsies were used as the gold standard. For the ex vivo study, prostate specimens were immersed in saline and scanned with the same ultrasound system immediately after radical prostatectomy. Entire surgical specimens were then embedded for histologic examination. The ultrasound rf data were analyzed using a 2-D Fourier transform algorithm. The resulting spectral parameters of both cancerous regions and non-cancerous regions were computed to quantitatively assess the prostatic tissue. Ultrasonic tissue-typing imaging using spectrum analysis technique reveals the physical properties (e.g., size, shape and stiffness) of biological tissues noninvasively. Two studies were carried out, after IRB approval, to determine how well this ultrasound technique can differentiate cancerous tissues inside the prostate. Ten patients with localized prostate cancer were enrolled in the in vivo study. Each patient was scanned with a conventional transrectal ultrasound (BsK Medical System, Hawk, 7.5 MHz probe) before the brachytherapy procedure. 3-D ultrasound radio-frequency (rf) data were acquired in a sequence of parallel axial scans which were 1 mm apart. Prior prostate needle biopsies were used as the gold standard. For the ex vivo study, prostate specimens were immersed in saline and scanned with the same ultrasound system immediately after radical prostatectomy. Entire surgical specimens were then embedded for histologic examination. The ultrasound rf data were analyzed using a 2-D Fourier transform algorithm. The resulting spectral parameters of both cancerous regions and non-cancerous regions were computed to quantitatively assess the prostatic tissue. ResultsFor the in vivo study, 40 cancerous vs. 40 non-cancerous regions were analyzed. For the ex vivo study, 24 cancerous vs. 24 non-cancerous regions were analyzed. The size of each region analyzed is 4 mm × 4 mm. For both studies, significant differences between cancerous and non-cancerous regions were found in three 2-D ultrasonic parameters (p < 0.001): peak value of radially-integrated spectral power (RISP), slope and intercept of angularly-integrated spectral power (AISP). For the in vivo study, 40 cancerous vs. 40 non-cancerous regions were analyzed. For the ex vivo study, 24 cancerous vs. 24 non-cancerous regions were analyzed. The size of each region analyzed is 4 mm × 4 mm. For both studies, significant differences between cancerous and non-cancerous regions were found in three 2-D ultrasonic parameters (p < 0.001): peak value of radially-integrated spectral power (RISP), slope and intercept of angularly-integrated spectral power (AISP). ConclusionsThe in vivo study demonstrated the feasibility of clinically employing this tissue-typing method for segmenting cancer-bearing regions inside the prostate. The ex vivo study further validated our ultrasound tissue-typing technique. These encouraging results in prostate cancer imaging are being used to plan additional studies in dose escalation of prostate cancer brachytherapy and IMRT The in vivo study demonstrated the feasibility of clinically employing this tissue-typing method for segmenting cancer-bearing regions inside the prostate. The ex vivo study further validated our ultrasound tissue-typing technique. These encouraging results in prostate cancer imaging are being used to plan additional studies in dose escalation of prostate cancer brachytherapy and IMRT